Anubha Sinha, MD
Gastroenterology · Flemington, NJNPI 1730107145
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,004 of the $1,267 with a category attached, or 79.2%. 20 manufacturers reported payments, led by AbbVie at 36.4% of the total. 2025 is the largest year on record at $452, 3.9 times the $116 reported in 2019. That places this record below the midpoint for gastroenterology clinicians in NJ, where the typical reported total is $2,298.
Across 63 payments — averaging $20.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$461
- Sanofi-aventis U.S. LLC$179
- Johnson & Johnson$154
- Novo Nordisk$99
- Daiichi Sankyo Inc.$77
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$44
- plus $253 from 14 others
What the payments were for
- Food & beverage$1,00479%
- Education$26321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 29 | $461 |
| Sanofi-aventis U.S. LLC | 2 | $179 |
| Johnson & Johnson | 6 | $154 |
| Novo Nordisk | 3 | $99 |
| Daiichi Sankyo Inc. | 5 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $44 |
| Braintree Laboratories, Inc. | 1 | $29 |
| Acera Surgical, Inc. | 1 | $27 |
| Sanofi | 1 | $21 |
| Abbott | 1 | $20 |
| GSK | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $16 |
| Bristol Myers Squibb | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| QOL Medical, LLC | 1 | $14 |
| Pfizer | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $12 |
How this compares
$1,267 in reported general payments places this provider in the 35th percentile of 701 gastroenterology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 16 | $1,678 |
| Omeprazole | 89 | $1,261 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 18 | $1,183 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 22 | $582 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 31 | $539 |
| Pantoprazole Sodium | 33 | $270 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Flemington
- Richard ArrigoFlemington$120K
- Vinod RustgiNew Brunswick$431K
- Zamir BrelviNewark$391K
- Adam ElfantMount Laurel$385K
- Devjit NayarHoboken$258K
- Lea ChenNew Brunswick$185K
- Alexander PerelmanWest Orange$160K
- Barry KaufmanEgg Harbor Township$157K
- Anish ShethPrinceton$151K
- Ramesh GuptaFair Lawn$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.